Trade Thomson Medical - A50sg CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.005 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.020345% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.001573% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | SGD | ||||||||
Margin | 5% | ||||||||
Stock exchange | Singapore | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Thomson Medical Group Ltd ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 0.048 |
Open* | 0.049 |
1-Year Change* | -26.87% |
Day's Range* | 0.048 - 0.049 |
52 wk Range | 0.05-0.08 |
Average Volume (10 days) | 4.44M |
Average Volume (3 months) | 77.01M |
Market Cap | 1.45B |
P/E Ratio | 39.86 |
Shares Outstanding | 26.44B |
Revenue | 355.77M |
EPS | 0.00 |
Dividend (Yield %) | 0.72727 |
Beta | 1.27 |
Next Earnings Date | Feb 5, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 19, 2024 | 0.048 | 0.000 | 0.00% | 0.048 | 0.048 | 0.048 |
Apr 18, 2024 | 0.049 | 0.000 | 0.00% | 0.049 | 0.049 | 0.049 |
Apr 17, 2024 | 0.048 | 0.000 | 0.00% | 0.048 | 0.049 | 0.048 |
Apr 16, 2024 | 0.049 | 0.001 | 2.08% | 0.048 | 0.049 | 0.048 |
Apr 15, 2024 | 0.049 | 0.000 | 0.00% | 0.049 | 0.049 | 0.049 |
Apr 12, 2024 | 0.050 | 0.000 | 0.00% | 0.050 | 0.050 | 0.049 |
Apr 11, 2024 | 0.049 | 0.000 | 0.00% | 0.049 | 0.050 | 0.049 |
Apr 8, 2024 | 0.049 | 0.000 | 0.00% | 0.049 | 0.049 | 0.049 |
Apr 5, 2024 | 0.050 | -0.002 | -3.85% | 0.052 | 0.052 | 0.050 |
Apr 3, 2024 | 0.052 | 0.000 | 0.00% | 0.052 | 0.052 | 0.052 |
Apr 2, 2024 | 0.054 | 0.001 | 1.89% | 0.053 | 0.054 | 0.053 |
Apr 1, 2024 | 0.052 | 0.002 | 4.00% | 0.050 | 0.053 | 0.050 |
Mar 26, 2024 | 0.050 | 0.000 | 0.00% | 0.050 | 0.051 | 0.050 |
Mar 25, 2024 | 0.049 | 0.000 | 0.00% | 0.049 | 0.049 | 0.049 |
Mar 22, 2024 | 0.049 | 0.000 | 0.00% | 0.049 | 0.049 | 0.049 |
Mar 21, 2024 | 0.050 | 0.001 | 2.04% | 0.049 | 0.050 | 0.049 |
Mar 18, 2024 | 0.049 | 0.000 | 0.00% | 0.049 | 0.050 | 0.049 |
Mar 15, 2024 | 0.050 | 0.001 | 2.04% | 0.049 | 0.050 | 0.049 |
Mar 11, 2024 | 0.050 | 0.001 | 2.04% | 0.049 | 0.050 | 0.049 |
Mar 8, 2024 | 0.050 | 0.001 | 2.04% | 0.049 | 0.050 | 0.049 |
Thomson Medical Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, October 8, 2024 | ||
Time (UTC) 07:30 | Country SG
| Event Thomson Medical Group Ltd Annual Shareholders Meeting Thomson Medical Group Ltd Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2018 | |
---|---|---|---|---|---|
Total revenue | 355.769 | 333.706 | 240.398 | 327.798 | 215.61 |
Revenue | 355.769 | 333.706 | 240.398 | 327.798 | 215.61 |
Total Operating Expense | 273.509 | 241.899 | 191.586 | 373.203 | 178.427 |
Selling/General/Admin. Expenses, Total | 117.484 | 107.92 | 74.88 | 101.151 | 60.33 |
Depreciation / Amortization | 21.07 | 17.93 | 17.954 | 26.039 | 11.528 |
Interest Expense (Income) - Net Operating | |||||
Unusual Expense (Income) | |||||
Other Operating Expenses, Total | 75.575 | 60.728 | 49.25 | 175.731 | 61.912 |
Operating Income | 82.26 | 91.807 | 48.812 | -45.405 | 37.183 |
Net Income Before Taxes | 55.203 | 69.298 | 26.182 | -79.519 | 22.041 |
Net Income After Taxes | 41.056 | 58.585 | 16.91 | -93.916 | 14.7 |
Minority Interest | -4.501 | -4.823 | -2.673 | -3.075 | -3.857 |
Net Income Before Extra. Items | 36.555 | 53.762 | 14.237 | -96.991 | 10.843 |
Net Income | 36.555 | 53.762 | 14.237 | -99.196 | 2.161 |
Income Available to Common Excl. Extra. Items | 36.555 | 53.762 | 14.237 | -96.991 | 10.843 |
Income Available to Common Incl. Extra. Items | 36.555 | 53.762 | 14.237 | -99.196 | 2.161 |
Diluted Net Income | 36.555 | 53.762 | 14.237 | -99.196 | 2.161 |
Diluted Weighted Average Shares | 26446.7 | 26441.1 | 26441 | 26382 | 26262.5 |
Diluted EPS Excluding Extraordinary Items | 0.00138 | 0.00203 | 0.00054 | -0.00368 | 0.00041 |
Dividends per Share - Common Stock Primary Issue | 0.0004 | 0.00115 | 0.00015 | 0 | 0.00025 |
Diluted Normalized EPS | 0.00139 | 0.00203 | 0.00054 | -0.00135 | 0.00048 |
Cost of Revenue, Total | 59.38 | 55.321 | 49.502 | 70.282 | 44.657 |
Gross Profit | 296.389 | 278.385 | 190.896 | 257.516 | 170.953 |
Interest Income (Expense), Net Non-Operating | -26.413 | -21.52 | -21.222 | -32.054 | -14.048 |
Other, Net | -0.644 | -0.989 | -1.408 | -2.06 | -1.094 |
Total Extraordinary Items | -2.205 | -8.682 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total revenue | 171.77 | 183.999 | 188.327 | 145.379 | 123.758 |
Revenue | 171.77 | 183.999 | 188.327 | 145.379 | 123.758 |
Cost of Revenue, Total | 29.684 | 29.696 | 28.675 | 26.646 | 24.95 |
Gross Profit | 142.086 | 154.303 | 159.652 | 118.733 | 98.808 |
Total Operating Expense | 134.738 | 138.771 | 127.413 | 114.486 | 101.042 |
Selling/General/Admin. Expenses, Total | 55.393 | 62.581 | 58.537 | 49.519 | 41.186 |
Depreciation / Amortization | 10.821 | 10.249 | 9.371 | 8.559 | 8.806 |
Interest Expense (Income) - Net Operating | |||||
Unusual Expense (Income) | 0.006 | 0.187 | |||
Other Operating Expenses, Total | 38.84 | 36.245 | 30.83 | 29.756 | 25.913 |
Operating Income | 37.032 | 45.228 | 60.914 | 30.893 | 22.716 |
Interest Income (Expense), Net Non-Operating | -14.508 | -12.549 | -11.512 | -10.997 | -10.879 |
Net Income Before Taxes | 22.524 | 32.679 | 49.402 | 19.896 | 11.837 |
Net Income After Taxes | 16.778 | 24.278 | 44.634 | 13.951 | 7.175 |
Minority Interest | -3.018 | -1.483 | -3.357 | -1.466 | -1.039 |
Net Income Before Extra. Items | 13.76 | 22.795 | 41.277 | 12.485 | 6.136 |
Total Extraordinary Items | |||||
Net Income | 13.76 | 22.795 | 41.277 | 12.485 | 6.136 |
Income Available to Common Excl. Extra. Items | 13.76 | 22.795 | 41.277 | 12.485 | 6.136 |
Income Available to Common Incl. Extra. Items | 13.76 | 22.795 | 41.277 | 12.485 | 6.136 |
Diluted Net Income | 13.76 | 22.795 | 41.277 | 12.485 | 6.136 |
Diluted Weighted Average Shares | 26452.4 | 26441.1 | 26441.1 | 26441 | 26441 |
Diluted EPS Excluding Extraordinary Items | 0.00052 | 0.00086 | 0.00156 | 0.00047 | 0.00023 |
Dividends per Share - Common Stock Primary Issue | 0.0004 | 0 | 0.00115 | 0 | 0.00015 |
Diluted Normalized EPS | 0.00052 | 0.00087 | 0.00156 | 0.00047 | 0.00024 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 440.884 | 320.547 | 250.468 | 285.764 | 503.546 |
Cash and Short Term Investments | 286.591 | 161.591 | 122.678 | 159.975 | 115.165 |
Cash | 78.018 | 60.643 | 70.688 | 41.008 | 31.687 |
Short Term Investments | 83.478 | ||||
Total Receivables, Net | 58.334 | 56.188 | 23.269 | 19.725 | 19.375 |
Accounts Receivable - Trade, Net | 35.357 | 37.428 | 12.504 | 12.25 | 14.657 |
Total Inventory | 91.819 | 98.809 | 100.897 | 102.209 | 148.456 |
Prepaid Expenses | 1.466 | 1.215 | 1.207 | 1.396 | 1.403 |
Other Current Assets, Total | 2.674 | 2.744 | 2.417 | 2.459 | 219.147 |
Total Assets | 1447.78 | 1364.94 | 1285.78 | 1294.31 | 1489.07 |
Property/Plant/Equipment, Total - Net | 430.551 | 457.452 | 446.446 | 419.086 | 345.784 |
Property/Plant/Equipment, Total - Gross | 537.286 | 553.547 | 534.145 | 499.794 | 413.989 |
Accumulated Depreciation, Total | -106.735 | -96.095 | -87.699 | -80.708 | -68.205 |
Goodwill, Net | 474.781 | 483.372 | 486.043 | 486.666 | 488.077 |
Intangibles, Net | 6.866 | 0.689 | 0.706 | 0.787 | 1.053 |
Long Term Investments | 93.722 | 101.964 | 102.115 | 102.012 | 150.606 |
Other Long Term Assets, Total | 0.978 | 0.919 | 0 | ||
Total Current Liabilities | 120.037 | 338.501 | 83.326 | 73.495 | 356.011 |
Accounts Payable | 15.192 | 16.936 | 11.878 | 14.97 | |
Accrued Expenses | 41.955 | 42.512 | 27.892 | 26.778 | |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 18.685 | 232.988 | 6.117 | 5.625 | 236.636 |
Other Current Liabilities, Total | 44.205 | 46.065 | 37.439 | 26.122 | 79.14 |
Total Liabilities | 948.34 | 833.262 | 795.938 | 816.419 | 775.028 |
Total Long Term Debt | 744.107 | 409.868 | 624.958 | 657.03 | 341.665 |
Long Term Debt | 735.629 | 401.421 | 619.084 | 649.241 | 341.665 |
Deferred Income Tax | 7.333 | 7.353 | 10.618 | 10.298 | 6.96 |
Minority Interest | 76.001 | 76.661 | 76.194 | 74.964 | 70.095 |
Other Liabilities, Total | 0.862 | 0.879 | 0.842 | 0.632 | 0.297 |
Total Equity | 499.442 | 531.681 | 489.84 | 477.896 | 714.038 |
Common Stock | 2364.5 | 2364.5 | 2364.5 | 2364.5 | 2772.21 |
Retained Earnings (Accumulated Deficit) | -1734.51 | -1740.95 | -1791.23 | -1805.47 | -2056.7 |
Unrealized Gain (Loss) | 0.856 | 0.975 | -0.474 | ||
Other Equity, Total | -131.411 | -92.846 | -83.424 | -81.131 | -0.999 |
Total Liabilities & Shareholders’ Equity | 1447.78 | 1364.94 | 1285.78 | 1294.31 | 1489.07 |
Total Common Shares Outstanding | 26441.1 | 26441.1 | 26441 | 26441 | 26176.5 |
Cash & Equivalents | 208.573 | 100.948 | 51.99 | 118.967 | |
Payable/Accrued | 40.235 | ||||
Capital Lease Obligations | 8.478 | 8.447 | 5.874 | 7.789 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total Current Assets | 440.884 | 313.847 | 320.547 | 271.968 | 250.468 |
Cash and Short Term Investments | 286.591 | 153.469 | 161.591 | 137.421 | 122.678 |
Cash & Equivalents | 286.591 | 153.469 | 161.591 | 137.421 | 122.678 |
Total Receivables, Net | 62.474 | 63.554 | 60.147 | 33.646 | 26.893 |
Accounts Receivable - Trade, Net | 62.474 | 63.554 | 60.147 | 33.646 | 26.893 |
Total Inventory | 91.819 | 96.824 | 98.809 | 100.901 | 100.897 |
Other Current Assets, Total | |||||
Total Assets | 1447.78 | 1341.33 | 1364.94 | 1312.78 | 1285.78 |
Property/Plant/Equipment, Total - Net | 430.551 | 444.434 | 457.452 | 452.217 | 446.446 |
Intangibles, Net | 6.866 | 4.498 | 484.061 | 486.479 | 486.749 |
Long Term Investments | 93.722 | 98.625 | 101.964 | 102.118 | 102.115 |
Total Current Liabilities | 120.037 | 120.545 | 338.501 | 312.213 | 83.326 |
Payable/Accrued | 83.819 | 92.221 | 86.541 | 69.033 | 65.601 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 18.685 | 10.269 | 232.988 | 230.705 | 6.117 |
Other Current Liabilities, Total | 17.533 | 18.055 | 18.972 | 12.475 | 11.608 |
Total Liabilities | 948.34 | 831.016 | 833.262 | 813.768 | 795.938 |
Total Long Term Debt | 744.107 | 629.391 | 409.868 | 413.672 | 624.958 |
Long Term Debt | 735.629 | 621.157 | 401.421 | 409.287 | 619.084 |
Capital Lease Obligations | 8.478 | 8.234 | 8.447 | 4.385 | 5.874 |
Deferred Income Tax | 7.333 | 7.654 | 7.353 | 10.845 | 10.618 |
Minority Interest | 76.001 | 72.631 | 76.661 | 76.189 | 76.194 |
Other Liabilities, Total | 0.862 | 0.795 | 0.879 | 0.849 | 0.842 |
Total Equity | 499.442 | 510.31 | 531.681 | 499.014 | 489.84 |
Common Stock | 2364.5 | 2364.5 | 2364.5 | 2364.5 | 2364.5 |
Retained Earnings (Accumulated Deficit) | -1734.51 | -1748.56 | -1740.95 | -1782.19 | -1791.23 |
Other Equity, Total | -131.411 | -106.427 | -92.846 | -83.294 | -83.424 |
Total Liabilities & Shareholders’ Equity | 1447.78 | 1341.33 | 1364.94 | 1312.78 | 1285.78 |
Total Common Shares Outstanding | 26441.1 | 26441.1 | 26441.1 | 26441 | 26441 |
Other Long Term Assets, Total | 0.978 | 0.222 | 0.919 | ||
Unrealized Gain (Loss) | 0.856 | 0.797 | 0.975 | ||
Goodwill, Net | 474.781 | 479.7 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | 69.298 | 26.182 | -79.519 | 22.041 | 27.455 |
Cash From Operating Activities | 92.802 | 61.253 | 78.597 | 40.504 | 52.168 |
Cash From Operating Activities | 17.556 | 17.537 | 25.622 | 11.24 | 10.225 |
Amortization | 0.374 | 0.417 | 0.744 | 2.662 | 5.085 |
Non-Cash Items | 21.898 | 21.915 | 126.894 | 10.711 | 5.378 |
Cash Taxes Paid | 8.313 | 6.54 | 14.314 | 11.074 | 7.734 |
Cash Interest Paid | 22.112 | 22.251 | 35.986 | 19.211 | 10.332 |
Changes in Working Capital | -16.324 | -4.798 | 4.856 | -6.15 | 4.025 |
Cash From Investing Activities | -29.436 | -37.572 | -100.587 | -47.284 | -23.958 |
Capital Expenditures | -27.753 | -37.29 | -75.427 | -24.139 | -24.205 |
Other Investing Cash Flow Items, Total | -1.683 | -0.282 | -25.16 | -23.145 | 0.247 |
Cash From Financing Activities | -23.483 | -58.821 | 30.942 | 10.188 | -37.605 |
Financing Cash Flow Items | -23.291 | -21.181 | -43.461 | -21.678 | -12.184 |
Issuance (Retirement) of Stock, Net | 0.006 | 30.786 | 0.131 | 0.65 | |
Issuance (Retirement) of Debt, Net | 3.768 | -37.64 | 50.227 | 31.735 | -26.071 |
Foreign Exchange Effects | -1.075 | -0.276 | -0.356 | -0.038 | 1.166 |
Net Change in Cash | 38.808 | -35.416 | 8.596 | 3.37 | -8.229 |
Total Cash Dividends Paid | -3.966 | -6.61 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 32.679 | 69.298 | 19.896 | 14.345 | |
Cash From Operating Activities | 52.811 | 92.802 | 30.511 | 35.071 | 33.585 |
Cash From Operating Activities | 9.831 | 17.556 | 8.352 | 17.537 | 8.946 |
Amortization | 0.418 | 0.374 | 0.207 | 0.417 | 0.202 |
Non-Cash Items | 12.75 | 21.898 | 10.828 | 21.915 | 11.875 |
Cash Taxes Paid | 7.453 | 8.313 | 4.098 | 6.54 | 3.333 |
Cash Interest Paid | 15.979 | 22.112 | 11.028 | 22.251 | 11.188 |
Changes in Working Capital | -2.867 | -16.324 | -8.772 | -4.798 | -1.783 |
Cash From Investing Activities | -7.315 | -29.436 | -10.865 | -37.572 | -20.731 |
Capital Expenditures | -6.454 | -27.753 | -10.814 | -37.29 | -20.671 |
Other Investing Cash Flow Items, Total | -0.861 | -1.683 | -0.051 | -0.282 | -0.06 |
Cash From Financing Activities | -51.41 | -23.483 | -5.013 | -58.821 | -52.871 |
Financing Cash Flow Items | -16.71 | -23.291 | -12.135 | -21.181 | -9.386 |
Total Cash Dividends Paid | -30.407 | -3.966 | -3.966 | ||
Issuance (Retirement) of Stock, Net | 0.006 | ||||
Issuance (Retirement) of Debt, Net | -4.293 | 3.768 | 11.088 | -37.64 | -43.485 |
Foreign Exchange Effects | -1.633 | -1.075 | 0.017 | -0.276 | 0.379 |
Net Change in Cash | -7.547 | 38.808 | 14.65 | -35.416 | -39.638 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Thomson Medical Company profile
Track the Thomson Medical share price and spot the best levels for profitable CFD trades
Thomson Medical Group Limited is one of the largest healthcare service providers in the South-East Asian region with operations in Malaysia and Singapore. Headquartered in Singapore, the Group’s healthcare divisions include Thomson Medical and TMC Life Sciences Berhad.
Founded in 1979, Thomson Medical is the leading provider of healthcare services for children and women in Singapore. The company operates the notorious Thomson Medical Centre, which is focused in the areas of Obstetrics & Gynecology and Pediatrics, and a network of specialist medical facilities and clinics in Singapore. Thomson Medical offers health screening services, diagnostic imaging, gynecological oncology, specialist dermatology, dentistry, musculoskeletal and sports medicine, medical aesthetics and traditional Chinese medicine.
TMC Life Sciences Berhad operates as a multidisciplinary healthcare company, which is listed on Bursa Malaysia. It manages a tertiary Tropicana Medical Centre and the award-winning TMC Fertility Centre, which is a leading provider of assisted reproduction services in Malaysia. TMC Life Sciences also manages Thomson Iskander Medical Hub, which operates as an integrated educational, medical and wellness hub.
Over the years, Thomson Medical Group has broadened its activity to include new services to care for women beyond maternity, to transform into Asia’s preferred health system. The Group owns a 9.23 hectare freehold waterfront land in Johor Bahru’s City Centre. It is planning to build an integrated healthcare city, which will be able to meet the growing healthcare needs of the people in the region.
Thomson Medical stock price is listed on the Mainboard of the Singapore Exchange under the ticker symbol A50. With Capital.com, you can access the Thomson Medical Group share price in real time.
Looking at the Thomson Medical stock performance at the beginning of 2021, we can note that the first quarter was a very bullish period for the A50 stock. The price of the Thomson Medical Group stock surged from 0.050 SGD on January 1, 2021 to 0.12 SGD on March 2, 2021. In the last 1-year period the Thomson Medical stock price fluctuated within a range of 0.038-0.12 SGD.
According to the half-year financial statement announcement for the period ended December 31, 2020, the Group’s revenue declined by 1.3 per cent to $116.6m compared to $118.2m for the same period in 2019. The decrease was mainly driven by the lower patient loads in Malaysia and Singapore due to restrictions imposed by the authorities in an effort to contain the Covid-19 virus. Meanwhile, the company’s EBITDA increased by 32.6 per cent from $24m to $31.9m due to the received grants and property tax rebates granted by the Singapore government to support employers.
You can trade A50 shares today with CFDs directly from the interactive Thomson Medical share price chart at Capital.com. Follow the Thomson Medical share price live and decide whether to open a long or a short trade, depending on the stock’s performance. Track the A50 stock and include this Singapore-based healthcare company in your investment portfolio.
Industry: | Healthcare Facilities & Services (NEC) |
101 Thomson Road
#20-04/05 United Square
307591
SG
Income Statement
- Annual
- Quarterly
News
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com